Announcement to approve the lifting of non-competition restrictions for directors at the 2021 Annual General Meeting

1. Date of the shareholders’ meeting resolution: July 16, 2021 2. Name and title of the managerial officer with permission to engage in competitive conduct: Independent Director: Howard Lee Director: …

Announcement on the elected Independent Director at the 2021 Annual General Meeting

1. Date of occurrence of the change: July 16, 2021 2. Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor): independent director …

Announcement of resolution items from 2021 Annual General Meeting

1. Date of the shareholders’ meeting: July 16, 2021 2. Important resolutions I. Profit distribution/deficit compensation: Resolution on acknowledgment of the 2020 Earnings Distribution Loss Off-setting 3. Important resolutions II. …

The Company’s Board of Directors resolved to change the date of 2021 Shareholders’ Meeting in accordance with the instructions of FSC

1.Date of the board of directors resolution: June 28, 2021 2.General shareholders’ meeting date: July 16, 2021 3.General shareholders’ meeting time: 9:00AM 4.General shareholders’ meeting location: Courtyard Taipei, 7F Supernova …

The company has acquired ordinary shares of Obigen Pharma, Inc.

1. Name and nature of the underlying assets (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield, etc.): ordinary shares of Obigen Pharma, …

The company will postpone the annual shareholders’ meeting to June 21, 2021 in accordance with the instructions of FSC (distribution of electronic voting shareholders’ complimentary gift)

1. Date of occurrence: May 24, 2021 2. Due to “Measures for public companies to postpone shareholders’ meetings for pandemic prevention”, the Company suspended the convening of a shareholders’ meetings …

The Company will postpone the Annual Shareholders’ meeting on June 21, 2021 in accordance with the instructions of FSC

1. Date of occurrence: May 20, 2021 2. Due to “Measures for public companies to postpone shareholders’ meetings for pandemic prevention”, the Company suspended the convening of a shareholders’ meetings …

Supplementary statement for 2021 shareholders’ meeting (change of location)

1. Date of the board of directors’ resolution: May 19, 2021 2. General shareholders’ meeting date: Jun 21, 2021 3. General shareholders’ meeting location: Courtyard Taipei, 7F Supernova Ballroom (7F, …

OBI-999 completes its Phase 1 safety evaluation and demonstrates its safety with no major concerns, proceeding to Phase 2 as planned

1. Date of occurrence of the event: May 13, 2021 2. Company name: OBI Pharma Inc. 3. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4. …

Supplementary statement for 2021 shareholders’ meeting (additional matters)

1. Date of the board of directors’ resolution: May 7, 2021 2. General shareholders’ meeting date: Jun 21, 2021 3. General shareholders’ meeting location: Masterlink Securities Education and Training Center …